TY - JOUR
KW - Hub and spoke
KW - Medication treatment for opioid use disorders (MOUD)
KW - medication-assisted treatment
KW - opioid use disorder
KW - system of care
AU - R. A. Rawson
AU - T. Rieckmann
AU - S. Cousins
AU - M. McCann
AU - R. Pearce
A1 - 
AD - Vermont Center for Behavior and Health, Lerner School of Medicine, University of Vermont, 1 South Prospect Street, Burlington, VT 05733, USA; Integrated Substance Abuse Programs, Geffen School of Medicine, University of California at Los Angeles, 11075 Santa Monica Blvd., Ste. 200, Los Angeles, CA 90025, USA. Electronic address: rrawson@uvm.edu.; GreenField Health, Portland, OR, USA; School of Medicine, Department of Psychiatry, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, CB669, Portland, OR 97239, USA.; Integrated Substance Abuse Programs, Geffen School of Medicine, University of California at Los Angeles, 11075 Santa Monica Blvd., Ste. 200, Los Angeles, CA 90025, USA.; Vermont Center for Behavior and Health, Lerner School of Medicine, University of Vermont, 1 South Prospect Street, Burlington, VT 05733, USA.; Vermont Center for Behavior and Health, Lerner School of Medicine, University of Vermont, 1 South Prospect Street, Burlington, VT 05733, USA.
BT - Preventive medicine
C5 - Opioids & Substance Use
CY - United States
JF - Preventive medicine
M1 - Journal Article
PB - Elsevier Inc
PP - United States
PY - 2019
SN - 1096-0260; 0091-7435
SP - 105785
T1 - Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system
T2 - Preventive medicine
TI - Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system
U1 - Opioids & Substance Use
U2 - 31362002
VL - 128
VO - 1096-0260; 0091-7435
Y1 - 2019
Y2 - Nov
ER -